Abstract
The present chapter was aimed to provide a comprehensive view toward the quality and bio-safety of selected lead molecules (Chapter 4) designed against the Brucella militensis 16M drug targets based on chemical absorption, distribution, metabolism, excretion, and toxicity (ADMET) analysis. Now-a-days, the applicability of ADMET analysis plays key roles in drug discovery and development. Therefore, the pharmacokinetic/pharmacodynamic properties for best potential ligand molecules were determined in this study using ADMET. In the present work the in silico analysis of ADME prediction for drug along with molecular descriptors calculation, drug likeness prediction, drug toxicity prediction, drug toxicity prediction was carried out by the PreADMET tool. The pharmacokinetic properties of the protein kinase inhibitors were identified by using FAFDrugs2 and the drug differentiation was done by ADME-Tox. Furthermore, quantitative structure activity relationships of lead molecules were also studied using Molinspiration Property Calculator (mipc). The results demonstrated that a total of 27 best lead molecules were identified by PreADMET exhibiting good biological activities like ion channel modulation, kinase inhibition activity, protease inhibition activity, enzyme inhibition activity against potential Brucella melitensis 16M drug targets. This in silico approach provides valuable information about the biological safety of humans, pharmacokinetic properties of drugs as well as their quality in terms of QSAR.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.